Matthew Stanton
Stock Analyst at Jefferies
(0.52)
# 3,923
Out of 4,880 analysts
5
Total ratings
50%
Success rate
-26.78%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $7.30 | +9.66% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.30 | +150.97% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $21.74 | +1.20% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $31.77 | +101.45% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $7.30
Upside: +9.66%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.30
Upside: +150.97%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $21.74
Upside: +1.20%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $31.77
Upside: +101.45%